NEXIMMUNE, INC. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8bbd4de7-1f29-49a7-b804-0e73339af4b2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-33.0M | 2023-01-01 – 2023-12-31 | evidence 0001538210-24-000003 |
| FY 2022 | $-63.1M | 2022-01-01 – 2022-12-31 | evidence 0001538210-23-000007 |
| FY 2021 | $-53.3M | 2021-01-01 – 2021-12-31 | evidence 0001538210-22-000008 |
| FY 2020 | $-27.9M | 2020-01-01 – 2020-12-31 | evidence 0001538210-22-000008 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).